Rachel E. Hayden

692 total citations
14 papers, 579 citations indexed

About

Rachel E. Hayden is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Rachel E. Hayden has authored 14 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Genetics. Recurrent topics in Rachel E. Hayden's work include Aldose Reductase and Taurine (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Rachel E. Hayden is often cited by papers focused on Aldose Reductase and Taurine (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Rachel E. Hayden collaborates with scholars based in United Kingdom, Germany and United States. Rachel E. Hayden's co-authors include Christopher M. Bunce, Mark T. Drayson, J.P. Ride, Farhat L. Khanim, Nicholas Davies, Jane Birtwistle, Joanne C. Mountford, Quang T. Luong, Richard M. Green and Julian C. Desmond and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Rachel E. Hayden

14 papers receiving 572 citations

Peers

Rachel E. Hayden
Zuping Xia United States
Paul Shapiro United States
Xiaoying Lan China
Kato L. Perlman United States
Scilla Latini Denmark
Yelena Zabelina United States
Xianping Shi China
Joanna M. Day United Kingdom
Celia Garcı́a-Prieto United States
David E. Lyons United States
Zuping Xia United States
Rachel E. Hayden
Citations per year, relative to Rachel E. Hayden Rachel E. Hayden (= 1×) peers Zuping Xia

Countries citing papers authored by Rachel E. Hayden

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Hayden more than expected).

Fields of papers citing papers by Rachel E. Hayden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Hayden. The network helps show where Rachel E. Hayden may publish in the future.

Co-authorship network of co-authors of Rachel E. Hayden

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Hayden. A scholar is included among the top collaborators of Rachel E. Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Hayden. Rachel E. Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Southam, Andrew D., Farhat L. Khanim, Rachel E. Hayden, et al.. (2015). Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids. Cancer Research. 75(12). 2530–2540. 43 indexed citations
2.
3.
Hayden, Rachel E., Guy Pratt, Claudia Roberts, Mark T. Drayson, & Christopher M. Bunce. (2011). Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leukemia & lymphoma. 53(4). 537–549. 32 indexed citations
4.
Lilly, Andrew J., Farhat L. Khanim, Rachel E. Hayden, et al.. (2010). Nm23-H1 Indirectly Promotes the Survival of Acute Myeloid Leukemia Blast Cells by Binding to More Mature Components of the Leukemic Clone. Cancer Research. 71(3). 1177–1186. 16 indexed citations
5.
Murray, J. A. H., Farhat L. Khanim, Rachel E. Hayden, et al.. (2010). Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML). British Journal of Haematology. 149(1). 65–69. 28 indexed citations
6.
Mirbahai, Leda, et al.. (2009). Use of a molecular beacon to track the activity of base excision repair protein OGG1 in live cells. DNA repair. 9(2). 144–152. 32 indexed citations
7.
Hayden, Rachel E., et al.. (2009). Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy. BMC Cell Biology. 10(1). 31–31. 18 indexed citations
8.
Birtwistle, Jane, Rachel E. Hayden, Farhat L. Khanim, et al.. (2009). The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 662(1-2). 67–74. 68 indexed citations
9.
Khanim, Farhat L., Rachel E. Hayden, Jane Birtwistle, et al.. (2009). Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia. PLoS ONE. 4(12). e8147–e8147. 63 indexed citations
10.
Davies, Nicholas, Rachel E. Hayden, Paul J. Simpson, et al.. (2009). AKR1C Isoforms Represent a Novel Cellular Target for Jasmonates alongside Their Mitochondrial-Mediated Effects. Cancer Research. 69(11). 4769–4775. 53 indexed citations
11.
Khanim, Farhat L., Charlotte Bradbury, Julie Arrazi, et al.. (2008). Elevated FOSB‐expression; a potential marker of valproate sensitivity in AML. British Journal of Haematology. 144(3). 332–341. 17 indexed citations
12.
Hotze, A.C.G., Nikolas J. Hodges, Rachel E. Hayden, et al.. (2008). Supramolecular Iron Cylinder with Unprecedented DNA Binding Is a Potent Cytostatic and Apoptotic Agent without Exhibiting Genotoxicity. Chemistry & Biology. 15(12). 1258–1267. 72 indexed citations
13.
14.
Desmond, Julian C., Joanne C. Mountford, Mark T. Drayson, et al.. (2003). The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.. PubMed. 63(2). 505–12. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuping Xia Breakdown of academic impact, for papers by Paul Shapiro Breakdown of academic impact, for papers by Xiaoying Lan Breakdown of academic impact, for papers by Kato L. Perlman Breakdown of academic impact, for papers by Scilla Latini Breakdown of academic impact, for papers by Yelena Zabelina Breakdown of academic impact, for papers by Xianping Shi Breakdown of academic impact, for papers by Joanna M. Day Breakdown of academic impact, for papers by Celia Garcı́a-Prieto Breakdown of academic impact, for papers by David E. Lyons
Rankless by CCL
2026